Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling ...
10d
Zacks Investment Research on MSNHere is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending StockVertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...
Navina, a clinical intelligence company, closed a $55 million Series C funding round. The round was led by a division of ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Two years after launching its generative AI assistant Bard — later rebranded as Gemini — Google has now introduced what it ...
Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced the successful conclusion of the eleventh Annual Genedata Partner Symposium (March 31?April 1 ...
If most of our work happens in the digital domain, why should our assistants only be flesh and blood analogues, asks Satyen K ...
Can generative AI (gen AI) rip things apart and then try to glue it all back together with more insight, more intelligence, more efficiency, and more value? It really depends on what the application ...
17d
Zacks Investment Research on MSNCRISPR Therapeutics Stock Trades Near 52-Week Low: Time to Buy or Sell?Shares of CRISPR Therapeutics CRSP closed at $40.97 on Tuesday, close to their 52-week low of $36.52. This decline in CRSP stock is mainly due to a lack of pipeline updates, which is not sitting well ...
At close: 21 March at 4:00:00 pm GMT-4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results